Table 1.

Training set plasma performance of single markers [NDRG4 and GATA5 (A); FOXE1 and SYNE1 (B)]

A
	NDRG4		GATA5
Patient group	Positive	Sensitivity	Positive	Sensitivity
Stage I	7/43	16%	6/43	14%
Stage II	5/44	11%	4/44	9%
Stage III	16/46	35%	8/46	17%
Stage IV	13/21	62%	10/21	48%
Case total	41/154	27%	28/154	18%
		Specificity		Specificity
Control	22/442	95%	5/444	99%

B
	FOXE1		SYNE1
Patient group	Positive	Sensitivity	Positive	Sensitivity
Stage I	15/43	35%	12/43	28%
Stage II	19/44	43%	23/44	52%
Stage III	23/46	50%	21/46	46%
Stage IV	14/21	67%	16/46	76%
Case total	71/154	46%	72/154	47%
		Specificity		Specificity
Control	32/444	93%	19/444	96%